_:n2824037930f04caa9a6e3de5e28a44adxb2
<http://schema.org/name>
"This undated image provided by Merck &amp; Co. shows their new antiviral medication. The drugmaker has said its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths. The U.S. Food and Drug Administration will ask its outside experts to review Merck&#8217;s pill to treat COVID-19 at a meeting in late November. Regulators announced the November 30 meeting on Thursday, Oct. 14, 2021 signaling they will conduct a detailed review of the drug&#8217;s safety and effectiveness. (Merck &amp; Co. via AP)"
<https://www.cnyhomepage.com/news/business-news/fda-unlikely-to-rule-on-mercks-covid-pill-before-december/>